Shanghai Dermatology Hospital, Shanghai 200443, PR China.
School of Pharmacy, Fudan University, Key Laboratory of Smart Drug Delivery of MOE and PLA, Shanghai 201203, PR China.
Drug Discov Today. 2018 Jan;23(1):181-186. doi: 10.1016/j.drudis.2017.09.017. Epub 2017 Oct 5.
Transcutaneous immunization (TCI) is a promising alternative to vaccine delivery via the subcutaneous and intramuscular routes because of the unique immunological characteristics of the skin. However, the stratum corneum (SC) prevents entry of most therapeutic compounds into the body. Several physical devices have been developed to overcome the SC barrier, but still damage the skin. However, by targeting antigens to the abundant perifollicular antigen-presenting cells (APCs), the transfollicular route might be a promising approach for TCI without compromising the skin barrier.
经皮免疫(TCI)是一种有前途的疫苗传递替代方法,可通过皮下和肌肉途径,因为皮肤具有独特的免疫学特性。然而,角质层(SC)阻止了大多数治疗化合物进入体内。已经开发了几种物理设备来克服 SC 屏障,但仍会损害皮肤。然而,通过将抗原靶向到丰富的毛囊周围抗原呈递细胞(APCs),经毛囊途径可能是一种有前途的 TCI 方法,而不会损害皮肤屏障。